TSE:TRI

Thomson Reuters Corp (TRI.TO)

124.88
-1.74 (1.37%)
as of Jul 3, 2026, 8:00:00 pm Market Open.
221 watching
0
Investor Insights
star iconJul 3, 2026, 12:00 am

This summary was created by AI, based on 36 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) is currently facing scrutiny due to fears that AI may disrupt its core legal and financial data services. Despite its strong fundamentals, including a solid balance sheet and consistent revenue performance, investor sentiment is cautious amid potential AI competition. While some experts highlight TRI's proprietary data as an essential asset that AI tools cannot easily replicate, others express concern over the company's competitive positioning moving forward. Many analysts suggest that TRI's valuation, although lower than past highs, remains elevated in the context of growth expectations. Ultimately, there is a general consensus that the stock, while presenting attractive opportunities for long-term investors, is undergoing a transitional phase marked by market volatility and shifting investor perceptions regarding its future performance in light of AI advancements.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
LexisNexis, LNN
BUY
With the stock market going up, this company is attractive.
TOP PICK
Earnings where a little disappointing. Feels they are getting back on track, producing a lot of cash. Sales are a quite strongly. Could have a dividend increase.
DON'T BUY
Their products are not having a particularly good time, and in fact are declining. Have not been able to rally through the stock market rally. A classic under performer and if the market should weaken it will drop more so.
BUY
They do their job very well. 12/15% earnings growth. A very solid, steady stock.
TOP PICK
Was hit hard last year by the strong Cdn$. Has also had slower growth. Last week they had an earnings warning. This has brought it down to a good price. A cash flow rich business.
BUY
Loves this company. Likes their strategy. Expect them to grow 6/7 percent per year.
HOLD
Continuing to hit its quarterly earnings targets.
DON'T BUY
Model price is $32, dead money. Wouldnt touch it, above model price.
TOP PICK
It has got some pretty decent growth and earnings coming through. Good repeat business coming through from the scientific and legal side.
DON'T BUY
The trouble with this company is that they report in US$. Good business and globally diversified but very sensitive to changes in currency.
BUY
Well positioned. Could benefit from a period of market consolidation. It also looks attractive on a technical basis. Safe money.
BUY
We are at the bottom of the economical cycle so expects things will pick up.
TOP PICK
(Top pick Sept 10/03. Up 0.8%.) Earnings are stable. Expects a P/E expansion.
DON'T BUY
Never seems to go up and the dividend doesn't pay that much. Refers Transcontinental. Cdn$ hurts. A well-run company but not sure if it will ever break out..
TOP PICK
A defensive holding. Business has lagged. Trades at a reasonable valuation. Lots of cash flow. A cyclical play on improvements in the capital markets.
Showing 556 to 570 of 715 entries